THURSDAY, July 25, 2024 (HealthDay News) — Medicare Advantage plans are touted as a great alternative to traditional Medicare, offering seniors easier access to doctors, hospitals and prescription drugs. But access to a good Medicare Advantage plan relies heavily on where a person lives, a new study finds. People areContinue Reading

THURSDAY, May 30, 2024 (HealthDay News) — Cancer patients receive less effective treatment at hospitals that mainly serve minority communities, a new study shows. More than 9% of cancer patients are treated at hospitals where a significant percentage of patients are from minority groups, researchers say. Those patients are lessContinue Reading

WEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heartContinue Reading

FRIDAY, March 22, 2024 (HealthDay News) — Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, U.S. officials announced Thursday. The move comes after the U.S. Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label earlierContinue Reading

WEDNESDAY, March 13, 2024 (HealthDay News) — Following a cyberattack on the largest health insurer in the United States last month, health care providers continue to scramble as insurance payments and prescription orders continue to be disrupted and physicians lose an estimated $100 million a day. That estimate was generatedContinue Reading